What is the Org number of Horus Pharma Nordic AB?

Horus Pharma Nordic AB is registered with Bolagsverket / SCB under Org 5593342388.

What is the revenue of Horus Pharma Nordic AB?

Horus Pharma Nordic AB reported revenue of 20,5 mn kr in 2024.

How many employees does Horus Pharma Nordic AB have?

Horus Pharma Nordic AB employs 3 people as of the latest annual report.

Who is the CEO of Horus Pharma Nordic AB?

Per Ola Jesper Freij is the CEO of Horus Pharma Nordic AB, in role since 2024.

Who is the chairman of Horus Pharma Nordic AB?

Claude Emile Claret chairs the board of Horus Pharma Nordic AB, in role since 2022.

Where is Horus Pharma Nordic AB headquartered?

Horus Pharma Nordic AB's registered address is Stockholm.

Riskpilot← Back to search

Get full access

Horus Pharma Nordic AB

ABActive

Org 5593342388StockholmWholesale of pharmaceutical and medical goods· NACE 4646Est. 2021 · 4 years old3 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2024	2023	2022
Revenue	20 517	1 663	0
Staff expenses	—	−4 328	—
EBITDA	−495	−4 877	−5 687
Depreciation & amort.	−0	—	−0
EBIT	−495	−4 877	−5 687
Net financials	−358	−111	−13
Profit before tax	−853	−4 988	−5 700
Tax	−0	—	−0
Net profit	−853	−4 988	−5 700

Balance sheet

SEK thousands

Item	2024	2023	2022
Total assets	12 326	8 014	2 263
Equity	25	156	13
Long-term debt	0	—	0
Short-term debt	12 301	7 858	2 250
Total debt	12 301	7 858	2 250

Financial ratios

5-year trend

EBITDA margin

−2,4 %

This company

15,8 %

Market median

This company

Market median

115% below market

20222024

Equity ratio

0,2 %

This company

38,2 %

Market median

This company

Market median

99% below market

20222024

Return on equity

<−999 %

This company

18,4 %

Market median

This company

Market median

>999% below market

20222024

Net profit margin

−4,2 %

This company

8,1 %

Market median

This company

Market median

152% below market

20222024

Asset turnover

1,66×

This company

1,12×

Market median

This company

Market median

48% above market

20222024

Debt / equity

492,04×

This company

0,62×

Market median

This company

Market median

>999% above market

20222024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-12-31
View PDF

Horus Pharma Nordic AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Horus Pharma Nordic AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Horus Pharma Nordic AB